tiprankstipranks
Trending News
More News >
Bafna Pharmaceuticals Limited (IN:BAFNAPH)
:BAFNAPH
India Market

Bafna Pharmaceuticals Limited (BAFNAPH) Ratios

Compare
0 Followers

Bafna Pharmaceuticals Limited Ratios

IN:BAFNAPH's free cash flow for Q1 2024 was ₹0.05. For the 2024 fiscal year, IN:BAFNAPH's free cash flow was decreased by ₹ and operating cash flow was ₹>-0.01. See a summary of the company’s cash flow.
Ratios
TTM
Mar 24Mar 23Mar 22Mar 21
Liquidity Ratios
Current Ratio
1.75 1.88 3.14 2.04 2.11
Quick Ratio
1.20 1.40 1.90 1.41 1.44
Cash Ratio
0.03 0.17 <0.01 0.03 0.48
Solvency Ratio
0.18 0.30 0.39 0.35 -1.07
Operating Cash Flow Ratio
0.18 0.11 0.49 -0.56 -2.01
Short-Term Operating Cash Flow Coverage
0.70 0.34 1.40 -1.30 0.00
Net Current Asset Value
₹ 276.27M₹ 311.83M₹ 240.35M₹ 199.73M₹ 159.78M
Leverage Ratios
Debt-to-Assets Ratio
0.17 0.18 0.10 0.18 0.04
Debt-to-Equity Ratio
0.30 0.31 0.14 0.28 0.06
Debt-to-Capital Ratio
0.23 0.24 0.13 0.22 0.06
Long-Term Debt-to-Capital Ratio
0.12 0.10 0.08 0.09 0.06
Financial Leverage Ratio
1.83 1.76 1.44 1.52 1.40
Debt Service Coverage Ratio
0.92 1.13 1.64 1.03 -21.58K
Interest Coverage Ratio
10.38 5.78 12.67 69.36 -1.97K
Debt to Market Cap
0.13 0.12 0.04 0.05 0.96
Interest Debt Per Share
11.29 10.55 4.04 6.71 12.76
Net Debt to EBITDA
1.57 0.80 0.78 1.42 -3.72
Profitability Margins
Gross Profit Margin
29.88%33.60%39.76%36.17%36.37%
EBIT Margin
6.09%11.84%6.74%8.31%-4.20%
EBITDA Margin
9.60%16.46%13.51%14.92%3.27%
Operating Profit Margin
15.59%10.21%7.80%8.63%-4.65%
Pretax Profit Margin
4.82%10.07%8.58%8.18%-4.43%
Net Profit Margin
4.82%9.83%6.13%8.18%-58.22%
Continuous Operations Profit Margin
4.82%9.83%6.13%8.18%-4.42%
Net Income Per EBT
100.00%97.60%71.38%100.00%1313.01%
EBT Per EBIT
30.92%98.67%110.04%94.81%95.38%
Return on Assets (ROA)
4.98%8.75%5.78%6.74%-34.68%
Return on Equity (ROE)
9.09%15.44%8.30%10.26%-48.38%
Return on Capital Employed (ROCE)
25.39%14.17%8.99%9.89%-3.64%
Return on Invested Capital (ROIC)
22.16%11.78%6.91%9.06%-48.07%
Return on Tangible Assets
5.04%8.85%5.78%6.74%-34.69%
Earnings Yield
3.88%5.84%1.74%1.79%-785.98%
Efficiency Ratios
Receivables Turnover
3.36 2.80 5.76 7.45 7.04
Payables Turnover
3.02 2.69 4.13 4.25 2.15
Inventory Turnover
3.61 3.45 2.53 2.94 2.37
Fixed Asset Turnover
3.01 2.87 2.19 1.94 1.21
Asset Turnover
1.03 0.89 0.94 0.82 0.60
Working Capital Turnover Ratio
3.75 3.04 2.82 3.21 -25.31
Cash Conversion Cycle
88.94 100.46 119.41 87.15 36.60
Days of Sales Outstanding
108.67 130.21 63.36 48.99 51.86
Days of Inventory Outstanding
101.20 105.88 144.34 124.01 154.13
Days of Payables Outstanding
120.94 135.63 88.29 85.85 169.39
Operating Cycle
209.88 236.09 207.70 173.00 206.00
Cash Flow Ratios
Operating Cash Flow Per Share
4.01 2.09 3.40 -5.75 -145.03
Free Cash Flow Per Share
-2.69 -1.38 0.21 -8.33 -151.07
CapEx Per Share
6.59 3.47 3.19 2.58 6.04
Free Cash Flow to Operating Cash Flow
-0.67 -0.66 0.06 1.45 1.04
Dividend Paid and CapEx Coverage Ratio
0.61 0.60 1.07 -2.23 -24.01
Capital Expenditure Coverage Ratio
0.61 0.60 1.07 -2.23 -24.01
Operating Cash Flow Coverage Ratio
0.39 0.22 0.89 -0.86 -11.37
Operating Cash Flow to Sales Ratio
0.06 0.04 0.09 -0.19 -0.81
Free Cash Flow Yield
-3.36%-1.68%0.16%-6.06%-1135.86%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
25.80 17.11 57.44 55.80 -0.13
Price-to-Sales (P/S) Ratio
1.24 1.68 3.52 4.57 0.07
Price-to-Book (P/B) Ratio
2.35 2.64 4.76 5.73 0.06
Price-to-Free Cash Flow (P/FCF) Ratio
-29.80 -59.39 610.56 -16.50 -0.09
Price-to-Operating Cash Flow Ratio
19.99 39.17 37.30 -23.89 -0.09
Price-to-Earnings Growth (PEG) Ratio
-0.74 0.15 -5.65 -0.55 >-0.01
Price-to-Fair Value
2.35 2.64 4.76 5.73 0.06
Enterprise Value Multiple
14.53 11.01 26.83 32.02 -1.45
Enterprise Value
EV to EBITDA
14.53 11.01 26.83 32.02 -1.45
EV to Sales
1.39 1.81 3.62 4.78 -0.05
EV to Free Cash Flow
-33.41 -64.02 628.95 -17.27 0.06
EV to Operating Cash Flow
22.41 42.22 38.43 -25.00 0.06
Tangible Book Value Per Share
33.47 30.42 26.58 24.00 216.26
Shareholders’ Equity Per Share
34.22 31.05 26.58 24.00 216.07
Tax and Other Ratios
Effective Tax Rate
0.00 0.02 0.17 -0.04 -12.20
Revenue Per Share
64.53 48.76 35.99 30.11 179.54
Net Income Per Share
3.11 4.79 2.21 2.46 -104.54
Tax Burden
1.00 0.98 0.71 1.00 13.13
Interest Burden
0.79 0.85 1.27 0.99 1.06
Research & Development to Revenue
0.01 <0.01 0.02 0.02 0.02
SG&A to Revenue
0.13 0.01 0.02 0.01 0.03
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
1.29 0.42 1.10 -2.34 18.22
Currency in INR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis